KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting
Kumquat Biosciences Inc.
Kumquat Biosciences Inc.
Incyte Corporation
Zhejiang Doer Biologics Co., Ltd.
Pfizer
Turning Point Therapeutics, Inc.
Genentech, Inc.
Boston Scientific Corporation
Boston Scientific Corporation
Erasca, Inc.
Chinese University of Hong Kong
Fudan University
Eisai Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Institute of Oncology Ljubljana
St. Jude Children's Research Hospital